Etamivan

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Anypodetos (talk | contribs) at 19:53, 27 November 2013 (SMILES, InChI/Key, ChemSpider ID; trade name in drugbox). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Etamivan
Clinical data
Trade namesAnalepticon
ATC code
Identifiers
  • N,N-diethyl-4-hydroxy-3-methoxybenzamide
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
CompTox Dashboard (EPA)
ECHA InfoCard100.005.599 Edit this at Wikidata
Chemical and physical data
FormulaC12H17NO3
Molar mass223.268 g/mol g·mol−1
3D model (JSmol)
  • CCN(CC)C(=O)C1=CC(=C(C=C1)O)OC
  • InChI=1S/C12H17NO3/c1-4-13(5-2)12(15)9-6-7-10(14)11(8-9)16-3/h6-8,14H,4-5H2,1-3H3
  • Key:BQJODPIMMWWMFC-UHFFFAOYSA-N
  (verify)

Etamivan (INN) or ethamivan (USAN), trade name Analepticon, is a respiratory stimulant drug[1] related to nikethamide. It was mainly used in the treatment of barbiturate overdose[2] and chronic obstructive pulmonary disease,[3] but has now largely fallen into disuse.

References

  1. ^ Hirsh K, Wang SC. Respiratory stimulant effects of ethamivan and picrotoxin. Journal of Pharmacology and Experimental Therapeutics. 1975 May;193(2):657-63.
  2. ^ Wheeldon PJ, Perry AW. The use of ethamivan in the treatment of barbiturate poisoning. Canadian Medical Association Journal. 1963 Jul 6;89:20-2.
  3. ^ Sproule BJ, Jans RL, Breitkreutz H, Mahon W. Effects of ethamivan in patients with chronic respiratory disease. Canadian Medical Association Journal. 1964 Dec 5;91:1203-8.


Stub icon

This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Etamivan&oldid=583570317"